Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation
Institute for Clinical and Experimental Medicine
Institute for Clinical and Experimental Medicine
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Institutes of Health Clinical Center (CC)
St. Jude Children's Research Hospital
Boston Children's Hospital
Hospices Civils de Lyon
University Hospital, Strasbourg, France
Thomas Jefferson University
Mayo Clinic
Incyte Corporation
Center for International Blood and Marrow Transplant Research
Massachusetts General Hospital
Masonic Cancer Center, University of Minnesota
Ohio State University
Institut Bergonié
Thomas Jefferson University
Thomas Jefferson University
Dana-Farber Cancer Institute